St Jude Medical
STJ
STJ was delisted on the 4th of January, 2017.
618 hedge funds and large institutions have $16.9B invested in St Jude Medical in 2015 Q3 according to their latest regulatory filings, with 67 funds opening new positions, 253 increasing their positions, 180 reducing their positions, and 54 closing their positions.
105% more call options, than puts
Call options by funds: $87.4M | Put options by funds: $42.7M
41% more repeat investments, than reductions
Existing positions increased: 253 | Existing positions reduced: 180
24% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 54
2% more funds holding
Funds holding: 608 → 618 (+10)
4% less capital invested
Capital invested by funds: $17.6B → $16.9B (-$659M)
43% less funds holding in top 10
Funds holding in top 10: 14 → 8 (-6)
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$113M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$55.2M |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$50.8M |
| 4 |
Millennium Management
New York
|
+$49.5M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$42.4M |
Top Sellers
STJ Hedge Fund Activity: Q3 2015 in Review
618 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in St Jude Medical (STJ) for Q3 2015, worth a combined $16.9B — down 3.8% from $17.6B a quarter earlier.
Buyers outnumbered sellers: 67 funds opened new STJ positions and 54 closed out — a net gain of 13 holders — while 253 added to existing stakes and 180 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $113M. The largest seller was Capital Research Global Investors, cutting an estimated $234M.
- 618 institutional investors held St Jude Medical (STJ) as of Q3 2015, up from 608 in Q2 2015.
- Funds reported $16.9B of St Jude Medical stock for Q3 2015, down 3.8% quarter-over-quarter.
- 67 funds opened new St Jude Medical positions in Q3 2015 and 54 closed out, a net change of +13 holders.
- The largest St Jude Medical buyer in Q3 2015 was Fidelity Investments, an estimated $113M added.
- The largest St Jude Medical seller in Q3 2015 was Capital Research Global Investors, an estimated $234M sold.
Based on aggregated 13F filings for Q3 2015.